EPIRUS Biopharmaceuticals, Inc. Liabilities Assumed
EPIRUS Biopharmaceuticals, Inc. reported Liabilities Assumed of -$4.90 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-31.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:LiabilitiesAssumed1 · last filed 2015-03-31
- EPIRUS Biopharmaceuticals, Inc. liabilities assumed for the quarter ending 2014-12-31 was $0.00.
- EPIRUS Biopharmaceuticals, Inc. liabilities assumed for fiscal 2014 was -$4.90M.
| Period end | Liabilities Assumed 3 month | Liabilities Assumed 9 month | Liabilities Assumed 12 month |
|---|---|---|---|
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | -$4.90M 10-K · filed 2015-03-31 | |
| 2014-09-30 | -$4.90M 10-Q · filed 2014-11-10 |